In the last 12 months, insiders at CorMedix Inc. ($CRMD) filed 144 transactions with the SEC: 3 open-market purchases totaling $341,203 and 15 sales totaling $6,371,807. Net insider sentiment: net selling.
CorMedix Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Todisco Joseph (Chief Executive Officer) — 24 transactions totaling $3,069,932
- Hurlburt Elizabeth (EVP) — 16 transactions totaling $2,351,714
- Dillione Janet (Director) — 25 transactions totaling $2,094,206
- Zelnick Kaufman Beth (Chief Legal Officer) — 16 transactions totaling $1,372,131
- Hurlburt Elizabeth (Chief Operating Officer) — 13 transactions totaling $1,167,307
View all SEC Filings for CorMedix Inc. (CRMD).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 4, 2026 | Todisco Joseph | Chief Executive Officer | A | Common Stock | 77156 | $0.00 | 774,749.0000 | 80,308 | 11.06% | 96.08% |
| Feb. 4, 2026 | Zelnick Kaufman Beth | Chief Legal Officer | A | Common Stock | 36006 | $0.00 | 269,108.0000 | 80,308 | 15.45% | 44.84% |
| Feb. 4, 2026 | Hurlburt Elizabeth | Chief Operating Officer | A | Common Stock | 36006 | $0.00 | 278,539.0000 | 80,308 | 14.85% | 44.84% |
| Jan. 26, 2026 | DUNTON ALAN W | Director | A | Common Stock | 30453 | $0.00 | 70,703.0000 | 80,308 | 75.66% | 37.92% |
| Jan. 26, 2026 | Lefkowitz Steven W | Director | A | Common Stock | 30453 | $0.00 | 158,103.0000 | 80,308 | 23.86% | 37.92% |
| Jan. 26, 2026 | Dillione Janet | Director | A | Common Stock | 30453 | $0.00 | 68,926.0000 | 80,308 | 79.15% | 37.92% |
| Jan. 26, 2026 | Kaplan Myron | Director | A | Common Stock | 30453 | $0.00 | 261,487.0000 | 80,308 | 13.18% | 37.92% |
| Jan. 23, 2026 | Todisco Joseph | Chief Executive Officer | F | Common Stock | 27306 | $7.27 | 697,593.0000 | 80,308 | 3.77% | 34.00% |
| Jan. 23, 2026 | Todisco Joseph | Chief Executive Officer | A | Common Stock | 225900 | $0.00 | 724,899.0000 | 80,308 | 45.27% | 100.00% |
| Jan. 23, 2026 | Hurlburt Elizabeth | Chief Operating Officer | F | Common Stock | 10778 | $7.27 | 242,533.0000 | 80,308 | 4.25% | 13.42% |
| Jan. 23, 2026 | Hurlburt Elizabeth | Chief Operating Officer | A | Common Stock | 93010 | $0.00 | 253,311.0000 | 80,308 | 58.02% | 100.00% |
| Jan. 23, 2026 | Zelnick Kaufman Beth | Chief Legal Officer | F | Common Stock | 8803 | $7.27 | 233,102.0000 | 80,308 | 3.64% | 10.96% |
| Jan. 23, 2026 | Zelnick Kaufman Beth | Chief Legal Officer | A | Common Stock | 72820 | $0.00 | 241,905.0000 | 80,308 | 43.07% | 90.68% |
| Jan. 23, 2026 | Blum Susan | Chief Financial Officer | F | Common Stock | 9767 | $7.27 | 132,739.0000 | 80,308 | 6.85% | 12.16% |
| Jan. 23, 2026 | Blum Susan | Chief Financial Officer | A | Common Stock | 72820 | $0.00 | 142,506.0000 | 80,308 | 104.50% | 90.68% |
| Jan. 26, 2026 | Duncan Gregory Scott | Director | A | Common Stock | 30453 | $0.00 | 68,786.0000 | 80,308 | 79.44% | 37.92% |
| Jan. 26, 2026 | Stewart Robert A | Director | A | Common Stock | 30453 | $0.00 | 66,453.0000 | 80,308 | 84.59% | 37.92% |
| Jan. 21, 2026 | Dillione Janet | Director | S | Common Stock | 10000 | $6.88 | 38,473.0000 | 80,308 | 20.63% | 12.45% |
| Jan. 12, 2026 | Hurlburt Elizabeth | Chief Operating Officer | F | Common Stock | 5794 | $7.15 | 160,301.0000 | 80,308 | 3.49% | 7.21% |
| Jan. 16, 2026 | Todisco Joseph | Chief Executive Officer | M | Stock Option (Right to Buy Common Stock) | 29585 | $0.00 | 411,245.0000 | 80,308 | 6.71% | 36.84% |
| Jan. 17, 2026 | Todisco Joseph | Chief Executive Officer | F | Common Stock | 22665 | $6.78 | 498,999.0000 | 80,308 | 4.34% | 28.22% |
| Jan. 16, 2026 | Todisco Joseph | Chief Executive Officer | M | Common Stock | 29585 | $3.38 | 521,664.0000 | 80,308 | 6.01% | 36.84% |
| Jan. 12, 2026 | Todisco Joseph | Chief Executive Officer | F | Common Stock | 17417 | $7.15 | 492,079.0000 | 80,308 | 3.42% | 21.69% |
| Jan. 8, 2026 | Seckler Michael David | Chief Commercial Officer | A | Common Stock | 133156 | $0.00 | 133,156.0000 | 80,308 | 9999.99% | 100.00% |
| Jan. 12, 2026 | Lefkowitz Steven W | Director | M | Stock Option (Right to Buy Common Stock) | 15000 | $0.00 | 0.0000 | 80,308 | 100.00% | 18.68% |
| Jan. 12, 2026 | Lefkowitz Steven W | Director | M | Common Stock | 15000 | $5.63 | 127,650.0000 | 80,308 | 13.32% | 18.68% |
| Jan. 2, 2026 | Zelnick Kaufman Beth | Chief Legal Officer | F | Common Stock | 11333 | $12.16 | 169,085.0000 | 80,308 | 6.28% | 14.11% |
| Jan. 2, 2026 | Hurlburt Elizabeth | Chief Operating Officer | F | Common Stock | 10895 | $12.16 | 166,095.0000 | 80,308 | 6.16% | 13.57% |
| Dec. 30, 2025 | DUNTON ALAN W | Director | S | Common Stock | 20000 | $13.00 | 40,250.0000 | 86,214,170 | 33.20% | 0.02% |
| Dec. 30, 2025 | DUNTON ALAN W | Director | M | Common Stock | 20000 | $4.03 | 60,250.0000 | 86,214,170 | 49.69% | 0.02% |
| Dec. 30, 2025 | DUNTON ALAN W | Director | M | Stock Option (Right to Buy Common Stock) | 20000 | $0.00 | 0.0000 | 86,214,170 | 100.00% | 0.02% |
| Dec. 18, 2025 | Todisco Joseph | Chief Executive Officer | S | Common Stock | 30000 | $12.00 | 509,496.0000 | 86,214,170 | 5.56% | 0.03% |
| Dec. 18, 2025 | Todisco Joseph | Chief Executive Officer | M | Stock Option (Right to Buy Common Stock) | 30000 | $0.00 | 370,000.0000 | 86,214,170 | 7.50% | 0.03% |
| Dec. 18, 2025 | Todisco Joseph | Chief Executive Officer | M | Common Stock | 30000 | $4.43 | 539,496.0000 | 86,214,170 | 5.89% | 0.03% |
| Dec. 9, 2025 | Dillione Janet | Director | M | Stock Option (Right to Buy Common Stock) | 15000 | $0.00 | 0.0000 | 86,214,170 | 100.00% | 0.02% |
| Dec. 9, 2025 | Dillione Janet | Director | M | Stock Option (Right to Buy Common Stock) | 19000 | $0.00 | 0.0000 | 86,214,170 | 100.00% | 0.02% |
| Dec. 9, 2025 | Dillione Janet | Director | S | Common Stock | 34000 | $12.00 | 48,473.0000 | 86,214,170 | 41.23% | 0.04% |
| Dec. 9, 2025 | Dillione Janet | Director | M | Common Stock | 15000 | $5.63 | 82,473.0000 | 86,214,170 | 22.23% | 0.02% |
| Dec. 9, 2025 | Dillione Janet | Director | M | Common Stock | 19000 | $9.55 | 67,473.0000 | 86,214,170 | 39.20% | 0.02% |
| Dec. 9, 2025 | Lefkowitz Steven W | Director | S | Common Stock | 40000 | $11.88 | 112,650.0000 | 86,214,170 | 26.20% | 0.05% |
| Dec. 2, 2025 | Dillione Janet | Director | M | Common Stock | 12210 | $4.03 | 60,683.0000 | 86,214,170 | 25.19% | 0.01% |
| Dec. 2, 2025 | Dillione Janet | Director | M | Common Stock | 15124 | $4.43 | 75,807.0000 | 86,214,170 | 24.92% | 0.02% |
| Dec. 2, 2025 | Dillione Janet | Director | M | Stock Option (Right to Buy Common Stock) | 19323 | $0.00 | 5,000.0000 | 86,214,170 | 79.44% | 0.02% |
| Dec. 2, 2025 | Dillione Janet | Director | M | Stock Option (Right to Buy Common Stock) | 15124 | $0.00 | 0.0000 | 86,214,170 | 100.00% | 0.02% |
| Dec. 2, 2025 | Dillione Janet | Director | M | Stock Option (Right to Buy Common Stock) | 12210 | $0.00 | 0.0000 | 86,214,170 | 100.00% | 0.01% |
| Dec. 2, 2025 | Dillione Janet | Director | S | Common Stock | 46657 | $10.00 | 48,473.0000 | 86,214,170 | 49.05% | 0.05% |
| Dec. 2, 2025 | Dillione Janet | Director | M | Common Stock | 19323 | $3.55 | 95,130.0000 | 86,214,170 | 25.49% | 0.02% |
| Nov. 24, 2025 | Dillione Janet | Director | M | Common Stock | 7790 | $4.03 | 64,263.0000 | 86,214,170 | 13.79% | 0.01% |
| Nov. 24, 2025 | Dillione Janet | Director | M | Stock Option (Right to Buy Common Stock) | 5677 | $0.00 | 24,323.0000 | 86,214,170 | 18.92% | 0.01% |
| Nov. 24, 2025 | Dillione Janet | Director | M | Stock Option (Right to Buy Common Stock) | 4876 | $0.00 | 15,124.0000 | 86,214,170 | 24.38% | 0.01% |
| Nov. 24, 2025 | Dillione Janet | Director | M | Stock Option (Right to Buy Common Stock) | 7790 | $0.00 | 12,210.0000 | 86,214,170 | 38.95% | 0.01% |
| Nov. 24, 2025 | Dillione Janet | Director | M | Stock Option (Right to Buy Common Stock) | 8000 | $0.00 | 0.0000 | 86,214,170 | 100.00% | 0.01% |
| Nov. 24, 2025 | Dillione Janet | Director | S | Common Stock | 26343 | $9.93 | 48,473.0000 | 86,214,170 | 35.21% | 0.03% |
| Nov. 24, 2025 | Dillione Janet | Director | M | Common Stock | 5677 | $3.55 | 74,816.0000 | 86,214,170 | 8.21% | 0.01% |
| Nov. 24, 2025 | Dillione Janet | Director | M | Common Stock | 4876 | $4.43 | 69,139.0000 | 86,214,170 | 7.59% | 0.01% |
| Nov. 24, 2025 | Dillione Janet | Director | M | Common Stock | 8000 | $2.85 | 56,473.0000 | 86,214,170 | 16.50% | 0.01% |
| Nov. 14, 2025 | Dillione Janet | Director | S | Common Stock | 30000 | $11.42 | 48,473.0000 | 86,214,170 | 38.23% | 0.03% |
| Oct. 23, 2025 | Kaplan Myron | Director | P | Common Stock | 25000 | $11.02 | 231,034.0000 | 86,214,170 | 12.13% | 0.03% |
| Sept. 16, 2025 | Duncan Gregory Scott | Director | M | Common Stock | 13333 | $8.32 | 38,333.0000 | 71,918,624 | 53.33% | 0.02% |
| Sept. 16, 2025 | Duncan Gregory Scott | Director | M | Stock Option (Right to Buy Common Stock) | 13333 | $0.00 | 6,667.0000 | 71,918,624 | 66.67% | 0.02% |
| Sept. 12, 2025 | DUNTON ALAN W | Director | S | Common Stock | 10000 | $13.13 | 40,250.0000 | 71,918,624 | 19.90% | 0.01% |
| Sept. 12, 2025 | DUNTON ALAN W | Director | M | Common Stock | 10000 | $3.55 | 50,250.0000 | 71,918,624 | 24.84% | 0.01% |
| Sept. 12, 2025 | DUNTON ALAN W | Director | M | Stock Option (Right to Buy Common Stock) | 10000 | $0.00 | 20,000.0000 | 71,918,624 | 33.33% | 0.01% |
| May 10, 2025 | Todisco Joseph | Chief Executive Officer | F | Common Stock | 21225 | $11.66 | 509,496.0000 | 68,975,418 | 4.00% | 0.03% |
| Sept. 12, 2025 | Todisco Joseph | Chief Executive Officer | M | Stock Option (Right to Buy Common Stock) | 50000 | $0.00 | 216,667.0000 | 71,918,624 | 18.75% | 0.07% |
| Sept. 12, 2025 | Todisco Joseph | Chief Executive Officer | M | Common Stock | 50000 | $3.47 | 559,496.0000 | 71,918,624 | 9.81% | 0.07% |
| Sept. 12, 2025 | Todisco Joseph | Chief Executive Officer | S | Common Stock | 50000 | $13.00 | 509,496.0000 | 71,918,624 | 8.94% | 0.07% |
| Sept. 11, 2025 | Hurlburt Elizabeth | Chief Operating Officer | S | Common Stock | 41121 | $13.08 | 176,990.0000 | 71,918,624 | 18.85% | 0.06% |
| Sept. 9, 2025 | Zelnick Kaufman Beth | Chief Legal Officer | M | Common Stock | 50000 | $3.30 | 230,418.0000 | 71,918,624 | 27.71% | 0.07% |
| Sept. 9, 2025 | Zelnick Kaufman Beth | Chief Legal Officer | S | Common Stock | 49600 | $13.41 | 180,818.0000 | 71,918,624 | 21.53% | 0.07% |
| Sept. 9, 2025 | Zelnick Kaufman Beth | Chief Legal Officer | S | Common Stock | 400 | $12.82 | 180,418.0000 | 71,918,624 | 0.22% | 0.00% |
| Sept. 9, 2025 | Zelnick Kaufman Beth | Chief Legal Officer | M | Stock Option (Right to Buy Common Stock) | 50000 | $0.00 | 150,000.0000 | 71,918,624 | 25.00% | 0.07% |
| Sept. 9, 2025 | Hurlburt Elizabeth | Chief Operating Officer | M | Common Stock | 12876 | $1.45 | 189,866.0000 | 71,918,624 | 7.27% | 0.02% |
| Sept. 9, 2025 | Hurlburt Elizabeth | Chief Operating Officer | S | Common Stock | 12876 | $13.51 | 176,990.0000 | 71,918,624 | 6.78% | 0.02% |
| Sept. 11, 2025 | Hurlburt Elizabeth | Chief Operating Officer | M | Common Stock | 41121 | $1.45 | 218,111.0000 | 71,918,624 | 23.23% | 0.06% |
| Sept. 9, 2025 | Hurlburt Elizabeth | Chief Operating Officer | M | Stock Option (Right to Buy Common Stock) | 12876 | $0.00 | 41,121.0000 | 71,918,624 | 23.85% | 0.02% |
| Sept. 11, 2025 | Hurlburt Elizabeth | Chief Operating Officer | M | Stock Option (Right to Buy Common Stock) | 41121 | $0.00 | 0.0000 | 71,918,624 | 100.00% | 0.06% |
| Aug. 29, 2025 | Hurlburt Elizabeth | Chief Operating Officer | F | Common Stock | 8424 | $14.83 | 176,990.0000 | 71,918,624 | 4.54% | 0.01% |
| Aug. 29, 2025 | Zelnick Kaufman Beth | Chief Legal Officer | F | Common Stock | 8880 | $14.83 | 180,418.0000 | 71,918,624 | 4.69% | 0.01% |
| Aug. 29, 2025 | Hurlburt Elizabeth | Chief Operating Officer | A | Common Stock | 69686 | $0.00 | 185,414.0000 | 71,918,624 | 60.22% | 0.10% |
| Aug. 29, 2025 | Blum Susan | Chief Financial Officer | A | Common Stock | 69686 | $0.00 | 69,686.0000 | 71,918,624 | 9999.99% | 0.10% |
| Aug. 29, 2025 | Zelnick Kaufman Beth | Chief Legal Officer | A | Common Stock | 69686 | $0.00 | 189,298.0000 | 71,918,624 | 58.26% | 0.10% |
| April 2, 2025 | Lefkowitz Steven W | Director | M | Common Stock | 20000 | $4.03 | 152,650.0000 | 68,975,418 | 15.08% | 0.03% |
| April 2, 2025 | Lefkowitz Steven W | Director | M | Stock Option (Right to Buy Common Stock) | 20000 | $0.00 | 0.0000 | 68,975,418 | 100.00% | 0.03% |
| April 1, 2025 | Todisco Joseph | Chief Executive Officer | M | Common Stock | 59170 | $3.38 | 530,721.0000 | 68,975,418 | 12.55% | 0.09% |
| April 1, 2025 | Todisco Joseph | Chief Executive Officer | M | Stock Option (Right to Buy Common Stock) | 59170 | $0.00 | 440,830.0000 | 68,975,418 | 11.83% | 0.09% |
| Jan. 17, 2025 | Duncan Gregory Scott | Director | A | Common Stock | 25000 | $0.00 | 25,000.0000 | 58,872 | 9999.99% | 42.47% |
| Jan. 17, 2025 | Todisco Joseph | Chief Executive Officer | F | Common Stock | 23977 | $12.17 | 471,551.0000 | 58,872 | 4.84% | 40.73% |
| Jan. 17, 2025 | DUNTON ALAN W | Director | A | Common Stock | 25000 | $0.00 | 40,250.0000 | 58,872 | 163.93% | 42.47% |
| Jan. 17, 2025 | Stewart Robert A | Director | A | Common Stock | 25000 | $0.00 | 36,000.0000 | 58,872 | 227.27% | 42.47% |
| Jan. 17, 2025 | Dillione Janet | Director | A | Common Stock | 25000 | $0.00 | 78,473.0000 | 58,872 | 46.75% | 42.47% |
| Jan. 17, 2025 | Kaplan Myron | Director | A | Common Stock | 25000 | $0.00 | 206,034.0000 | 58,872 | 13.81% | 42.47% |
| Jan. 17, 2025 | Lefkowitz Steven W | Director | A | Common Stock | 25000 | $0.00 | 132,650.0000 | 58,872 | 23.22% | 42.47% |
| Jan. 17, 2025 | Todisco Joseph | Chief Executive Officer | A | Common Stock | 187500 | $0.00 | 495,528.0000 | 58,872 | 60.87% | 100.00% |
| Jan. 10, 2025 | Hurlburt Elizabeth | EVP | F | Common Stock | 5790 | $11.19 | 115,728.0000 | 58,872 | 4.76% | 9.83% |
| Jan. 10, 2025 | David Matthew T | Chief Financial Officer | F | Common Stock | 6515 | $11.19 | 95,270.0000 | 58,872 | 6.40% | 11.07% |
| Jan. 10, 2025 | Todisco Joseph | Chief Executive Officer | F | Common Stock | 17829 | $11.19 | 308,028.0000 | 58,872 | 5.47% | 30.28% |
| Jan. 10, 2025 | Mistry Erin | EVP, Chief Commercial Officer | F | Common Stock | 5689 | $11.19 | 100,992.0000 | 58,872 | 5.33% | 9.66% |
| Jan. 2, 2025 | David Matthew T | Chief Financial Officer | A | Common Stock | 62500 | $0.00 | 110,434.0000 | 58,872 | 130.39% | 100.00% |
| Jan. 2, 2025 | David Matthew T | Chief Financial Officer | F | Common Stock | 8648 | $8.22 | 101,786.0000 | 58,872 | 7.83% | 14.69% |
| Jan. 2, 2025 | Zelnick Kaufman Beth | Chief Legal Officer | A | Common Stock | 87500 | $0.00 | 131,456.0000 | 58,872 | 199.06% | 100.00% |
| Jan. 2, 2025 | Zelnick Kaufman Beth | Chief Legal Officer | F | Common Stock | 11844 | $8.22 | 119,612.0000 | 58,872 | 9.01% | 20.12% |
| Jan. 2, 2025 | Hurlburt Elizabeth | EVP | A | Common Stock | 87500 | $0.00 | 132,897.0000 | 58,872 | 192.74% | 100.00% |
| Jan. 2, 2025 | Mistry Erin | EVP, Chief Commercial Officer | A | Common Stock | 62500 | $0.00 | 114,511.0000 | 58,872 | 120.17% | 100.00% |
| Jan. 2, 2025 | Mistry Erin | EVP, Chief Commercial Officer | F | Common Stock | 7830 | $8.22 | 106,681.0000 | 58,872 | 6.84% | 13.30% |
| Jan. 2, 2025 | Hurlburt Elizabeth | EVP | F | Common Stock | 11378 | $8.22 | 121,519.0000 | 58,872 | 8.56% | 19.33% |
| Dec. 12, 2024 | Zelnick Kaufman Beth | Chief Legal Officer | F | Common Stock | 6044 | $8.77 | 43,956.0000 | 58,825,221 | 12.09% | 0.01% |
| Dec. 12, 2024 | Zelnick Kaufman Beth | Chief Legal Officer | M | Restricted Stock Units | 12500 | $0.00 | 37,500.0000 | 58,825,221 | 25.00% | 0.02% |
| Dec. 12, 2024 | Zelnick Kaufman Beth | Chief Legal Officer | M | Common Stock | 12500 | $0.00 | 62,500.0000 | 58,825,221 | 25.00% | 0.02% |
| Dec. 12, 2024 | Zelnick Kaufman Beth | Chief Legal Officer | F | Common Stock | 6044 | $8.77 | 56,456.0000 | 58,825,221 | 9.67% | 0.01% |
| Oct. 31, 2024 | Mistry Erin | EVP, Chief Commercial Officer | P | Common Stock | 1500 | $9.99 | 52,011.0000 | 58,825,221 | 2.97% | 0.00% |
| Nov. 14, 2024 | Hurlburt Elizabeth | EVP | M | Common Stock | 34467 | $4.08 | 143,321.0000 | 58,825,221 | 31.66% | 0.06% |
| Nov. 14, 2024 | Hurlburt Elizabeth | EVP | M | Stock Option (Right to Buy Common Stock) | 25000 | $0.00 | 75,000.0000 | 58,825,221 | 25.00% | 0.04% |
| Nov. 14, 2024 | Hurlburt Elizabeth | EVP | M | Stock Option (Right to Buy Common Stock) | 62500 | $0.00 | 62,500.0000 | 58,825,221 | 50.00% | 0.11% |
| Nov. 14, 2024 | Hurlburt Elizabeth | EVP | M | Stock Option (Right to Buy Common Stock) | 34467 | $0.00 | 3,033.0000 | 58,825,221 | 91.91% | 0.06% |
| Nov. 14, 2024 | Hurlburt Elizabeth | EVP | M | Stock Option (Right to Buy Common Stock) | 9888 | $0.00 | 27,612.0000 | 58,825,221 | 26.37% | 0.02% |
| Nov. 14, 2024 | Hurlburt Elizabeth | EVP | M | Stock Option (Right to Buy Common Stock) | 8169 | $0.00 | 12,711.0000 | 58,825,221 | 39.12% | 0.01% |
| Nov. 14, 2024 | Hurlburt Elizabeth | EVP | M | Stock Option (Right to Buy Common Stock) | 3 | $0.00 | 53,997.0000 | 58,825,221 | 0.01% | 0.00% |
| Nov. 14, 2024 | Hurlburt Elizabeth | EVP | S | Common Stock | 140027 | $11.18 | 230,821.0000 | 58,825,221 | 37.76% | 0.24% |
| Nov. 14, 2024 | Hurlburt Elizabeth | EVP | M | Common Stock | 25000 | $3.47 | 230,821.0000 | 58,825,221 | 12.15% | 0.04% |
| Nov. 14, 2024 | Hurlburt Elizabeth | EVP | M | Common Stock | 62500 | $4.43 | 205,821.0000 | 58,825,221 | 43.61% | 0.11% |
| Nov. 14, 2024 | Hurlburt Elizabeth | EVP | M | Common Stock | 9888 | $5.63 | 108,854.0000 | 58,825,221 | 9.99% | 0.02% |
| Nov. 14, 2024 | Hurlburt Elizabeth | EVP | M | Common Stock | 8169 | $8.30 | 98,966.0000 | 58,825,221 | 9.00% | 0.01% |
| Nov. 14, 2024 | Hurlburt Elizabeth | EVP | M | Common Stock | 3 | $1.45 | 90,797.0000 | 58,825,221 | 0.00% | 0.00% |
| May 10, 2024 | Todisco Joseph | Chief Executive Officer | F | Common Stock | 26982 | $5.17 | 325,857.0000 | 57,503,154 | 7.65% | 0.05% |
| March 5, 2024 | Lefkowitz Steven W | Not found | A | Stock Option (Right to Buy Common Stock) | 30000 | $0.00 | 30,000.0000 | 50,902,931 | 9999.99% | 0.06% |
| March 5, 2024 | Stewart Robert A | Not found | A | Stock Option (Right to Buy Common Stock) | 30000 | $0.00 | 30,000.0000 | 50,902,931 | 9999.99% | 0.06% |
| March 5, 2024 | Kaplan Myron | Not found | A | Stock Option (Right to Buy Common Stock) | 30000 | $0.00 | 30,000.0000 | 50,902,931 | 9999.99% | 0.06% |
| March 5, 2024 | Dillione Janet | Not found | A | Stock Option (Right to Buy Common Stock) | 30000 | $0.00 | 30,000.0000 | 50,902,931 | 9999.99% | 0.06% |
| March 5, 2024 | DUNTON ALAN W | Not found | A | Stock Option (Right to Buy Common Stock) | 30000 | $0.00 | 30,000.0000 | 50,902,931 | 9999.99% | 0.06% |
| March 5, 2024 | Duncan Gregory Scott | Not found | A | Stock Option (Right to Buy Common Stock) | 30000 | $0.00 | 30,000.0000 | 50,902,931 | 9999.99% | 0.06% |
| March 13, 2024 | Todisco Joseph | Chief Executive Officer | P | Common Stock | 13561 | $3.74 | 352,839.0000 | 50,902,931 | 4.00% | 0.03% |
| Jan. 12, 2024 | Masson-Hurlburt Elizabeth | EVP, Head of Clinical Ops. | A | Common Stock | 50000 | $0.00 | 58,000.0000 | 50,902,931 | 625.00% | 0.10% |
| Jan. 12, 2024 | Masson-Hurlburt Elizabeth | EVP, Head of Clinical Ops. | F | Common Stock | 4603 | $3.47 | 53,397.0000 | 50,902,931 | 7.94% | 0.01% |
| Jan. 12, 2024 | Masson-Hurlburt Elizabeth | EVP, Head of Clinical Ops. | A | Stock Option (Right to Buy Common Stock) | 100000 | $0.00 | 100,000.0000 | 50,902,931 | 9999.99% | 0.20% |
| Jan. 12, 2024 | David Matthew T | Chief Financial Officer | A | Common Stock | 50000 | $0.00 | 53,150.0000 | 50,902,931 | 1587.30% | 0.10% |
| Jan. 12, 2024 | David Matthew T | Chief Financial Officer | F | Common Stock | 5216 | $3.47 | 47,934.0000 | 50,902,931 | 9.81% | 0.01% |
| Jan. 12, 2024 | David Matthew T | Chief Financial Officer | A | Stock Option (Right to Buy Common Stock) | 100000 | $0.00 | 100,000.0000 | 50,902,931 | 9999.99% | 0.20% |
| Jan. 12, 2024 | Mistry Erin | Chief Commercial Officer | A | Common Stock | 50000 | $0.00 | 54,900.0000 | 50,902,931 | 1020.41% | 0.10% |
| Jan. 12, 2024 | Mistry Erin | Chief Commercial Officer | F | Common Stock | 4389 | $3.47 | 50,511.0000 | 50,902,931 | 7.99% | 0.01% |
| Jan. 12, 2024 | Mistry Erin | Chief Commercial Officer | A | Stock Option (Right to Buy Common Stock) | 100000 | $0.00 | 100,000.0000 | 50,902,931 | 9999.99% | 0.20% |
| Jan. 12, 2024 | Todisco Joseph | Chief Executive Officer | A | Common Stock | 133333 | $0.00 | 353,059.0000 | 50,902,931 | 60.68% | 0.26% |
| Jan. 12, 2024 | Todisco Joseph | Chief Executive Officer | F | Common Stock | 13781 | $3.47 | 339,278.0000 | 50,902,931 | 3.90% | 0.03% |
| Jan. 12, 2024 | Todisco Joseph | Chief Executive Officer | A | Stock Option (Right to Buy Common Stock) | 266667 | $0.00 | 266,667.0000 | 50,902,931 | 9999.99% | 0.52% |